๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Hexamethylmelamine in ovarian cancer after failure of cisplatin-based multiple-agent chemotherapy

โœ Scribed by Gregory F. Rosen; John R. Lurain; Michael Newton

Book ID
119052869
Publisher
Elsevier Science
Year
1987
Tongue
English
Weight
484 KB
Volume
27
Category
Article
ISSN
0090-8258

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Advanced ovarian cancer in the elderly:
Advanced ovarian cancer in the elderly: results of consecutive trials with cisplatin-based chemotherapy
โœ Silvana Chiara; Rita Lionetto; Maura Vincenti; Milena Bruzzone; Maria Teresa Nob ๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 85 KB

From 1982 through 1996, 547 untreated advanced ovarian cancer patients were entered onto Gruppo Oncologico Nord-Ovest (GONO) consecutive randomized trials including cisplatin-based chemotherapy. End points of analysis included the influence of age on prognosis, toxicity, clinical/surgical response r

Five-year survival for cisplatin-based c
Five-year survival for cisplatin-based chemotherapy versus single-agent melphalan in patients with advanced ovarian cancer and optimal debulking surgery
โœ M. Steven Piver; James Fanning; Henry E. Sprance ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 542 KB

The purpose of this study was to evaluate 5-year survival and 5-year progression-free survival in previously untreated patients with advanced ovarian cancer treated with single-agent melphalan in which very few patients underwent optimal debulking surgery (<2 cm residual) as compared with the patien